NAV

Quinoline Yellow WS

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Quinoline Yellow WS
Accession Number
DB14231
Description
Not Available
Type
Small Molecule
Groups
Experimental
Synonyms
  • C.I. Food Yellow 13
  • D & C Yellow No. 10
  • D and C Yellow No. 10
  • D&C Yellow No. 10
  • Food Yellow 13
  • Japan Yellow 203

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Unlock Additional Data
AcebutololQuinoline Yellow WS may decrease the antihypertensive activities of Acebutolol.
AceclofenacThe risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Aceclofenac is combined with Quinoline Yellow WS.
AcemetacinThe risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Acemetacin is combined with Quinoline Yellow WS.
Acetylsalicylic acidThe therapeutic efficacy of Quinoline Yellow WS can be decreased when used in combination with Acetylsalicylic acid.
Agrostis gigantea pollenThe risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Agrostis gigantea pollen.
Agrostis stolonifera pollenThe risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Agrostis stolonifera pollen.
AlclofenacThe risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Alclofenac is combined with Quinoline Yellow WS.
AlfentanilThe risk or severity of hypertension can be increased when Alfentanil is combined with Quinoline Yellow WS.
AliskirenThe risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Quinoline Yellow WS.
AllopurinolThe risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinoline Yellow WS.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
No interactions found.

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
35SW5USQ3G
CAS number
8004-92-0
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
ChemSpider
23070
RxNav
1305564
Wikipedia
Quinoline_Yellow_WS

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on July 04, 2018 18:18 / Updated on June 12, 2020 10:53

Ddi 4